Cargando…
Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161741/ http://dx.doi.org/10.1016/j.eprac.2021.04.590 |
| _version_ | 1783700565016969216 |
|---|---|
| author | Bhattacharya, Supratik |
| author_facet | Bhattacharya, Supratik |
| author_sort | Bhattacharya, Supratik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8161741 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81617412021-05-28 Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study Bhattacharya, Supratik Endocr Pract Article Published by Elsevier Inc. 2021-06 2021-05-28 /pmc/articles/PMC8161741/ http://dx.doi.org/10.1016/j.eprac.2021.04.590 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bhattacharya, Supratik Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title | Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title_full | Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title_fullStr | Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title_full_unstemmed | Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title_short | Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study |
| title_sort | abstract #1003971: efficacy and safety of empagliflozin and linagliptin combination in non-hospitalized covid-19 positive patients with t2dm in real world setting: a single center retrospective study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161741/ http://dx.doi.org/10.1016/j.eprac.2021.04.590 |
| work_keys_str_mv | AT bhattacharyasupratik abstract1003971efficacyandsafetyofempagliflozinandlinagliptincombinationinnonhospitalizedcovid19positivepatientswitht2dminrealworldsettingasinglecenterretrospectivestudy |